Search

Your search keyword '"Glimm H"' showing total 343 results

Search Constraints

Start Over You searched for: Author "Glimm H" Remove constraint Author: "Glimm H"
343 results on '"Glimm H"'

Search Results

1. The German Network for Personalized Medicine to enhance patient care and translational research

2. Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib® versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]

3. Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial

4. Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma

5. Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma

7. The German Network for Personalized Medicine to enhance patient care and translational research

8. 99P Fibroblast activation protein alpha (FAP) as theranostic target in solitary fibrous tumor

11. Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers

12. 487P Randomized phase II study of trabectedin/olaparib compared to physician’s choice in subjects with previously treated advanced or recurrent solid tumors harboring DNA repair deficiencies

15. 196P Randomized phase II study of trabectedin/olaparib compared to physician’s choice in subjects with previously treated advanced or recurrent solid tumors harboring DNA repair deficiencies

19. Hematopoietic Ex Vivo Gene Transfer

20. Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway

21. NDRG1 prognosticates the natural course of disease in WHO grade II glioma

22. 1533P Gene expression-based prediction of pazopanib benefit in sarcomas

24. High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma*

25. Gene expression-based prediction of pazopanib benefit in sarcomas

26. Sarcoma classification by DNA methylation profiling

34. Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway.

41. Harmonization and standardization of panel-based tumour mutational burden (TMB) measurement: Real-world results and recommendations of the QuIP study

49. Randomized Phase 2 Study of Trabectedin/Olaparib Compared to Physician‘s Choice in Subjects with Previously Treated Advanced or Recurrent Solid Tumors Haboring DNA Repair Deficiencies (DKTK/NCT-PMO-1603, TOP-ART

50. Clinical outcome of personalised treatment guided by genome and transcriptome sequencing in patients with neuroendocrine neoplasms: Updated results from the German NCT/DKTK MASTER trial

Catalog

Books, media, physical & digital resources